Icon

NAMENDA XR (nda022525)- (7MG,14MG,21MG,28MG)

MEMANTINE HYDROCHLORIDE ABBVIE
7MG,14MG,21MG,28MG
Yes No
2029-Sep-24 Expired
None None
None No
NAMENDA XR is a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.
9 2 8
Total Other Developers 8
Drugs with Suitability No
7MG ** ** Down - 5
14MG ** ** Down - 5
21MG ** ** Down - 5
28MG ** ** Down - 5
NDA Sales Available Total Generic Sales Available
Yes 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** ***** *** ***** ******* *********** ****-*, **** **. *-* *** *-*-*, ******* ******** **** ***** **, ****. ****, ******* ****, ****. ****, *********, ****** ******* ******, ***** (***) ***
****** ******* ********* ******* ********* **** ***** ****** ***** *********** **. ***, ******* ****, *******, ***** ******, ***** (***) ***
****** ********* ****** *** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***
****** ****** ** ***** ** ****** ** ************** **., ***. *********** **** ******** **** ****, ******, ****** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.